Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6031 to 6045 of 7707 results

  1. Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners and funders. Researchers and investigators.

    Recommendation ID PH47/3 Question Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners

  2. Recommendation 1 Research studies and trials. Who should take action? Research councils, commissioners and funders.

    Recommendation ID PH47/1 Question Recommendation 1 Research studies and trials. Who should take action? Research councils, commissioners

  3. Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable bowel syndrome] (IBS) symptoms and patient-related outcomes?

    Recommendation ID CG61/4 Question Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable

  4. Repositioning:- When repositioning a person who is at risk of developing a pressure ulcer, what is the most effective position – and optimum frequency of repositioning – to prevent a pressure ulcer developing?

    Recommendation ID CG179/5 Question Repositioning:- When repositioning a person who is at risk of developing a pressure ulcer, what is the

  5. Reducing demands on health and social care services:- Do preventive oral health interventions in residential and nursing care homes reduce demands on other health and social care services?

    Recommendation ID NG48/5 Question Reducing demands on health and social care services:- Do preventive oral health interventions in residential

  6. Lifestyle factors to reduce the risk of pelvic floor dysfunction: What lifestyle factors reduce the risk of developing pelvic floor dysfunction (diet, reducing carbonated drink and caffeine intake)?

    Recommendation ID NG210/04 Question Lifestyle factors to reduce the risk of pelvic floor dysfunction: What lifestyle factors reduce the

  7. What measures would make up an effective, standardised approach to evaluation of condom distribution schemes?: How can we develop a standardised framework to evaluate condom schemes and what would be included in that evaluation?

    Recommendation ID NG68/1 Question What measures would make up an effective, standardised approach to evaluation of condom distribution

  8. What methods can improve the identification of women at high risk of postpartum psychosis and reduce this risk?

    Recommendation ID CG192/1 Question What methods can improve the identification of women at high risk of postpartum psychosis and reduce

  9. What structured group activities are effective at improving interpersonal functioning (social skills) for people with complex psychosis?

    Recommendation ID NG181/4 Question What structured group activities are effective at improving interpersonal functioning (social skills)

  10. What is the most clinical and cost-effective strategy, as identified by a consensus survey, for the perioperative management of anticoagulation treatment in people taking a vitamin K antagonist with a target international normalised ratio (INR) of more than 3 who need bridging therapy?

    Recommendation ID NG180/3 Question What is the most clinical and cost-effective strategy, as identified by a consensus survey, for the

  11. For how long should a person who has received emergency treatment for anaphylaxis be observed?

    Recommendation ID CG134/3 Question For how long should a person who has received emergency treatment for anaphylaxis be observed?

  12. Aside from mast cell tryptase, which other chemical inflammatory mediators offer potential as indicators of anaphylaxis?

    Recommendation ID CG134/1 Question Aside from mast cell tryptase, which other chemical inflammatory mediators offer potential as indicators

  13. What are the optimal management strategies for primary hyperparathyroidism during pregnancy?

    Recommendation ID NG132/4 Question What are the optimal management strategies for primary hyperparathyroidism during pregnancy?